Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Finland Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20054
20062
20071
20091
20101
20122
20134
20141
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb6
Novartis Pharmaceuticals5
Pfizer3
Amsterdam UMC, location VUmc1
Ariad Pharmaceuticals1
European LeukemiaNet1
European Society for Blood and Marrow Transplantation1
Norwegian University of Science and Technology1
St. Olavs Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive20
Leukemia4
Philadelphia Chromosome4
Bone Marrow Diseases3
Leukemia, Myeloid3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Hematologic Diseases2
Neoplasms by Histologic Type2
Blast Crisis1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.